|
LUNG | Pulmonx Corp |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.89 |
| Leverage | 56.59% |
| Market Cap | $ 67.4m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -56.6m |
| Margin | -61.36% |
Pulmonx Corporation, a medical technology company, designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. The company is headquartered in Redwood City, California.